Patents by Inventor Steven Mah

Steven Mah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SNPs OF APOLIPOPROTEIN B AND MODULATION OF THEIR EXPRESSION
    Publication number: 20150322429
    Abstract: Compounds, compositions and methods are provided for modulating the expression of apolipoprotein B. The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein B. Methods of using these compounds for modulation of apolipoprotein B expression and for diagnosis and treatment of diseases and conditions associated with expression of apolipoprotein B are provided.
    Type: Application
    Filed: December 2, 2014
    Publication date: November 12, 2015
    Inventors: Rosanne M. Crooke, Mark J. Graham, Steven Mah
  • SNPs of apolipoprotein B and modulation of their expression
    Patent number: 8916694
    Abstract: Compounds, compositions and methods are provided for modulating the expression of apolipoprotein B. The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein B. Methods of using these compounds for modulation of apolipoprotein B expression and for diagnosis and treatment of diseases and conditions associated with expression of apolipoprotein B are provided.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: December 23, 2014
    Assignee: Genzyme Corporation
    Inventors: Rosanne M. Crooke, Mark J. Graham, Steven Mah
  • SNPs of Apolipoprotein B and Modulation of Their Expression
    Publication number: 20110319469
    Abstract: Compounds, compositions and methods are provided for modulating the expression of apolipoprotein B. The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein B. Methods of using these compounds for modulation of apolipoprotein B expression and for diagnosis and treatment of diseases and conditions associated with expression of apolipoprotein B are provided.
    Type: Application
    Filed: January 28, 2011
    Publication date: December 29, 2011
    Applicant: Genzyme Corporation
    Inventors: Rosanne M. Crooke, Mark J. Graham, Steven Mah
  • Methods for Identifying Risk of Low Bmd and Treatments Thereof
    Publication number: 20070292849
    Abstract: Provided herein are methods for identifying a risk of low BMD in a subject, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating low BMD-related disorders, such as osteoporosis, and therapeutic and preventative methods applicable to osteoporosis. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: December 29, 2005
    Publication date: December 20, 2007
    Inventors: Steven Mah, Carolyn Hoyal-Wrightson, Stefan Kammerer, Matthew Nelson, Andreas Braun, Rikard Reneland
  • SNPs of apolipoprotein B and modulation of their expression
    Publication number: 20050287558
    Abstract: Compounds, compositions and methods are provided for modulating the expression of apolipoprotein B. The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein B. Methods of using these compounds for modulation of apolipoprotein B expression and for diagnosis and treatment of diseases and conditions associated with expression of apolipoprotein B are provided.
    Type: Application
    Filed: May 5, 2005
    Publication date: December 29, 2005
    Inventors: Rosanne Crooke, Mark Graham, Steven Mah